|
|
||||||||



* Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Mannheim, Universität Heidelberg, Mannheim, Germany; and
Abteilung für Neuropathologie, Klinikum der Universität zu Köln, Cologne, Germany
| Abstract |
|---|
|
|
|---|
production, whereas at a later stage of infection
(day 28) restimulation with Listeria-specific peptides
was required for the induction of IFN-
production by CD4 and CD8 T
cells. In contrast to splenic T cells, T cells in the brain did not
exhibit cytotoxic activity. Adoptively transferred T cells isolated
from the brains of Listeria-infected mice reduced the
bacterial load in cerebral listeriosis. The frequency of intracerebral
Listeria-specific T cells was partially regulated by the
time of exposure to Listeria and cross-regulated by CD4
and CD8 T cells. Collectively, these data reveal a novel T
cell-mediated pathway of active immunosurveillance of the CNS during
bacterial infections. | Introduction |
|---|
|
|
|---|
This scenario is also observed in infection with Listeria
monocytogenes, which is orally acquired by consumption of
contaminated food. In immunocompromised patients, the pathogen may
cause severe meningoencephalitis and/or brain abscess (1).
Survival and spread of Listeria in the host are critically
dependent on several bacterial virulence factors including the actA
protein, which is required for the intracellular movement of
Listeria (2, 3). The actA molecule is essential
for the accumulation of actin, and Listeria propels through
the host cell cytoplasm via its actin tail (2, 3).
L. monocytogenes mutants lacking actA are highly attenuated
and impaired in their ability to spread from cell to cell, although
they still elicit protective CD4 and CD8 T cell responses (4, 5). It is experimentally important that very high numbers of
actA-deficient Listeria can be applied to mice, which would
rapidly succumb to infection caused by an identical dose of
wild-type (WT)3
L. monocytogenes, and even immunodeficient mice, which
inevitably succumb to low dose infection with WT L.
monocytogenes, survive infection with the attenuated
actA mutant (6, 7). Studies in murine
listeriosis have revealed that control and elimination of L.
monocytogenes in peripheral organs including spleen and liver as
well as in the CNS are critically dependent on L.
monocytogenes-specific CD4 and CD8 T cells (8, 9). In
mice, CD4 and CD8 T cells are mainly directed against listeriolysin
(LLO) and the p60 protein of L. monocytogenes.
Immunodominant CD4 (LLO190201) and CD8
(LLO9199) as well as subdominant CD4
(p60367378) and CD8
(p60217225) epitopes against these proteins
have been identified (10).
In addition to control of the peripheral infection, active
immunosurveillance of the CNS may provide an elegant mechanism by which
to prevent bacteria-induced damage of the highly vulnerable brain,
which has long been considered an immune privileged site due to its
anatomical confinement beyond the blood-brain barrier, the lack of a
conventional lymphatic drainage, and the low level of MHC Ag expression
(11, 12, 13). The concept of an active immunosurveillance of
the brain during infection is supported by adoptive T cell transfer
experiments, which have shown that in normal animals i.v. injected
activated T cells home to the CNS irrespective of their Ag specificity
(14). To address the question of an active CD4 and CD8 T
cell-mediated immunosurveillance of the brain during systemic
infection, we studied intracerebral immune reactions in a model of
murine systemic listeriosis, in which the pathogen is strictly confined
to peripheral organs in the absence of CNS infection. Both WT L.
monocytogenes as well as the
actA mutant were used
to explore the impact of both virulence of Listeria and dose
of infection on the induction of immunosurveillance of the brain. These
experiments identified a novel pathway of T cell-mediated
immunosurveillance of the CNS and shed new light on the integration of
the CNS in immunological circuits intended to protect the highly
vulnerable brain from life-threatening infections.
| Materials and Methods |
|---|
|
|
|---|
(C57BL/6 x BALB/c-H2b/d)F1 (B6C) mice (Janvier, Le Genest St. Isle, France), 610 wk old, were kept under specific pathogen-free conditions throughout the experiments.
Bacteria and infection
WT L. monocytogenes (serovar 1/2a, EGD, SLCC
5835) and the L. monocytogenes
actA
mutant (15)were grown in tryptose soy broth, and aliquots
of log phase cultures were stored at -80°C. For infection of mice,
frozen aliquots were thawed and diluted appropriately in sterile
pyrogen-free PBS (pH 7.4). Mice were injected i.p. with 1 x
102 CFU of WT or
actA L.
monocytogenes, 1 x 104 CFU of WT or
actA L. monocytogenes, or 1 x
106 CFU of the
actA mutant for
primary infection. For secondary infection, 1 x
107
actA L. monocytogenes were
injected i.p. In each experiment, the numbers of Listeria
injected were controlled by plating the inoculum on tryptose soy
agar.
Determination of the bacterial load in brain and spleen
For determination of the bacterial load in brain and spleen, organs were dissected from sacrificed mice and homogenized with tissue grinders; 10-fold serial dilutions of the homogenates were plated on tryptose-soy agar. Bacterial colonies were counted after incubation at 37°C for 24 h.
Polymerase chain reaction
For determination of bacterial DNA in brain tissue, mice
infected i.p. with either WT or
actA L. monocytogenes
were anesthetized with Metofane (Janssen, Neuss, Germany) and
intracardially perfused with 0.9% NaCl solution to remove
intravascular leukocytes from the brain. Thereafter, brains were
dissected and snap-frozen in isopentane precooled by dry ice. Sagittal
frozen sections of representative areas of the brain including
forebrain covered by meninges, basal ganglia, ventricular system with
choroid plexus, brain stem, and cerebellum were used for isolation of
DNA. DNA was isolated by use of a DNA isolation kit (Nucleospin;
Clontech Laboratories, Palo Alto, CA). DNA was also isolated from
representative areas of the brain of mice intracerebrally infected 3
days before with either WT or
actA L. monocytogenes. DNA
(100 ng) was used as template per PCR. Integrity of DNA was controlled
by amplification of the murine
-actin gene. The p60 gene
of L. monocytogenes was amplified using the following
primers: forward primer 5'-CAA ACT GCT AAC ACA GCT ACT-3'; reverse
primer 5'-GCA CTT GAA TTG CTG TTA TTG-3'. PCR products were visualized
on ethidium bromide-stained 2% agarose gels.
Tissue preparation and immunohistochemistry
At the indicated days postinfection (p.i.), animals were anesthetized and intracardially perfused with 0.9% NaCl solution. Thereafter, brains were dissected, embedded in Tissue Tek OCT compound (Miles Scientific, Naperville, IL), snap-frozen in isopentane (Fluka, Neu-Ulm, Germany) precooled on dry ice, and stored at -80°C.
For immunohistochemistry, 5- to 7-µm cryostat sections were cut from the brain and stained for leukocyte common Ag (LCA; CD45), CD4, CD8, and Ly-6G (Gr-1) in an indirect peroxidase protocol using rat anti-mouse LCA (clone M1/9.3.4.HL.2), rat anti-mouse CD4 (clone G.K 1.5), rat anti-mouse CD8 (clone 2.43), and rat anti-mouse Ly6-G (Gr-1) (clone RB6-8C5), respectively, as primary Ab. Thereafter, sections were incubated with peroxidase-labeled goat anti-rat IgG (Amersham Pharmacia, Freiburg, Germany). F4/80+ macrophages and microglia were detected by incubating sections with F4/80 (clone F4/80), respectively, followed by biotinylated mouse anti-rat IgG F(ab')2 (Dianova, Hamburg, Germany), and peroxidase-labeled streptavidin complex (DAKO, Hamburg, Germany). L. monocytogenes was detected by incubating brain sections with a polyclonal rabbit anti-L. monocytogenes antiserum (Difco, Freiburg, Germany) followed by peroxidase-labeled goat anti-rabbit IgG F(ab')2 (Dianova). Peroxidase reaction products were visualized using 3,3'-diaminobenzidine hydrochloride (Sigma, Deisenhofen, Germany) and H2O2 as cosubstrate.
ELISPOT
The kinetics and magnitude of infiltration of L.
monocytogenes-specific CD4 and CD8 T cells to the brain were
determined by an IFN-
-specific ELISPOT. For the isolation of
cerebral leukocytes, mice were perfused, and their brains were
dissected and passed through a cell strainer. Thereafter, leukocytes
were separated by Percoll gradient centrifugation (Amersham Pharmacia)
as described previously (16). Isolated leukocytes at
concentrations of 2x103/well,
2x104/well, or 2x105/well
were placed in an ELISPOT plate coated with rat anti-mouse IFN-
mAb (Biosource, Camarillo, CA). Cerebral leukocytes were cocultured
with syngeneic B6C spleen cells from noninfected mice (4 x
105/well) preloaded with one of the
Listeria CD8 (LLO9199,
p60217225)- or CD4
(LLO190201,
p60367378)-specific peptides (Jerini, Berlin,
Germany) at 10-8 M (for CD8 peptides) and
10-6 M (for CD4 peptides) concentrations,
respectively, overnight. ELISPOT plates were developed with
biotin-labeled rat anti-mouse IFN-
(BD Biosciences, Heidelberg,
Germany), peroxidase-conjugated streptavidin (Dianova) and
aminoethylcarbazole dye solution (Sigma). Spots were counted
microscopically. The number of Listeria-specific T cells
against each peptide was expressed as the number of spots formed in
each well per 105 leukocytes.
Flow cytometry
Intracerebral leukocytes were isolated, and the percentage of
CD4 and CD8 T cells was assessed by staining with rat anti-mouse
CD4-PE and rat anti-mouse CD8-FITC. To analyze the activation state
of L. monocytogenes-specific CD8 and CD4 T cells, cerebral
leukocytes were either stimulated with LLO9199
(CD8 specific) and LLO190201 (CD4 specific) in
the presence of GolgiPlug (1 µl/ml; BD PharMingen, San Diego, CA) at
37°C for 6 h or left unstimulated. Thereafter, cells were washed
and stained with rat anti-mouse CD44-FITC or rat anti-mouse
CD62 ligand-FITC in combination with either anti-mouse
CD4-CyChrome (BD PharMingen) or rat anti-mouse CD8-CyChrome.
Finally, cells were fixed with Cytofix/Cytoperm (BD PharMingen)
solution and stained intracellularly with rat anti-mouse
IFN-
-PE (clone XMG1.2). In addition, cerebral leukocytes were
stained with hamster anti-mouse CD11c-PE or rat anti-mouse
Ly6G-PE combined with rat anti-mouse F4/80-FITC and rat
anti-mouse LCA-CyChrome. Moreover, cells were stained with
mouse anti-mouse NK1.1-PE and rat anti-mouse CD3-FITC or rat
anti-mouse B220-PE and rat anti-mouse LCA-CyChrome. Flow
cytometric analysis was performed using a FACScan (BD Biosciences, San
Jose, CA). Data were analyzed with CellQuest software (BD Biosciences).
Ampicillin treatment
To clear L. monocytogenes from infected mice, the drinking water of mice was supplemented with 2 mg/ml ampicillin (Sigma) starting 24 h p.i. Ampicillin treatment was performed for 5 days. Mice receiving ampicillin were sacrificed at day 7 p.i. The number of Listeria-specific CD8 (LLO9199) and CD4 (LLO190201) T cells in brain and spleen was determined by ELISPOT assay. The clearance of L. monocytogenes by ampicillin was monitored by agar plating of homogenized liver and spleen tissue.
T cell depletion
For depletion of CD4 and CD8 T cells, mice were treated with either rat anti-mouse CD4 (clone GK1.5) or rat anti-mouse CD8 (clone 2.43). Ab were purified from tissue culture supernatant by protein G chromatography, adjusted to a concentration of 2.5 mg/ml in 0.1 M PBS, sterile filtered, and stored at -30°C until use. Control mice were treated with rat IgG (Sigma). Ab were injected i.p. at a concentration of 0.5 mg/ml per mouse. Three days before i.p. infection with L. monocytogenes, mice received Ab for 3 consecutive days. Thereafter, Ab were injected at days 2 and 5 p.i. The efficiency of T cell depletion was monitored by flow cytometry. The number of Listeria-specific CD8 (LLO9199) and CD4 (LLO190201) T cells in the spleen and brain was determined by ELISPOT assay at day 7 p.i.
Adoptive transfer experiments
At day 7 p.i., intracerebral leukocytes were isolated and
resuspended in PBS for adoptive transfer. Three groups of recipient
mice receiving the whole leukocyte population isolated from the brain
(group 1), receiving cerebral leukocytes depleted of T cells (group 2),
and receiving PBS only (group 3) were included in this experiment. T
cell depletion was performed by MACS according to the manufacturers
instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). Briefly,
isolated cerebral leukocytes were incubated with rat anti-mouse
Thy-1.2-FITC (clone 53-2.1; BD Biosciences) followed by anti-FITC
beads (Miltenyi Biotec). Cells were passed through a depletion column,
and the T cell-depleted fraction was collected. The efficiency of T
cell depletion was monitored by flow cytometry. In all experiments,
>95% of Thy-1.2-expressing T cells were depleted. Each recipient
mouse was infected intracerebrally with 1 x
102
actA L. monocytogenes and,
immediately thereafter, received either 3 x
106 cerebral leukocytes in 200 µl PBS (i.v.) or
200 µl PBS instead of cells. Three days thereafter, recipient mice
were sacrificed, and the bacterial load in brains and spleens was
determined.
Cytotoxicity assay
At day 7 p.i., leukocytes were isolated from brains and
spleens. P815 (H2d) cells were used as target
cells and were coated with 10-6 M
LLO9199 at 37°C, 5%
CO2, in MEM
supplemented with 10% FCS. During
the last hour of peptide incubation, P815 cells were labeled with
51Cr (Amersham Pharmacia). Thereafter,
target cells were washed three times with MEM
to remove unbound
peptide and extracellular 51Cr. Isolated
leukocytes and target cells were incubated at E:T ratios of 200:1,
100:1, 30:1, 3:1, and 0.3:1 in triplicate. After incubation at 37°C
in 5% CO2 for 5 h, 100 µl of the
supernatant from each well were collected, and released
51Cr was counted in a gamma counter. The specific
release was calculated according to the following formula: 100 x
[(test release - spontaneous release)/(maximal release -
spontaneous release)], where test release was in the presence of
effector cells, spontaneous release was in the presence of medium
alone, and maximal release was in the presence of detergent.
Statistics
Students t test was used for comparison of the means between sample groups. Values of p of SD.
| Results |
|---|
|
|
|---|
To study whether a systemic infection with L.
monocytogenes induces recruitment of Listeria-specific
T cells to the brain, leukocytes of uninfected and
Listeria-infected mice were isolated from the brain and
analyzed by flow cytometry. At day 7 after i.p. infection with WT and
actA L. monocytogenes, the percentage of both
intracerebral CD4 and CD8 T cells was increased (Fig. 1
, BF) as compared with
uninfected animals (Fig. 1
A). This increase was correlated
with the number of applied Listeria; maximal numbers were
observed in mice infected with 1 x 106
actA L. monocytogenes, a dose that is lethal for mice
when the WT strain is used for infection. Using identical numbers of
Listeria for infection, the increase of intracerebral CD4
and CD8 T cells was slightly more pronounced in mice infected with the
WT strain than in those infected with
actA L.
monocytogenes (compare Fig. 1
, B and C, with
Fig. 1
, D and E).
|
actA L. monocytogenes (day
7 p.i.) were isolated and restimulated in an ELISPOT assay with
Listeria peptides specific for either CD8
(LLO9199) or CD4 T cells
(LLO190201). In general, the WT strain
induced a stronger intracerebral Listeria-specific CD4 and
CD8 T cell response than did the
actA mutant. This
difference was statistically significant after infection with 1 x
104 WT and
actA L. monocytogenes
(p < 0.01 for LLO9199, p <
0.01 for LLO190201). The highest number of
intracerebral L. monocytogenes-specific CD4 and CD8 T cells
was induced by infection with 1 x 106
actA L. monocytogenes. In both WT- and
actA-infected mice, the LLO9199
CD8 T cell epitope induced a stronger response as compared with the
LLO190201 CD4 T cell epitope (Fig. 1Systemic listeriosis is not associated with entry of bacteria into the CNS
To analyze whether the recruitment of Listeria-specific
T cells to the brain was due to an invasion of the brain by
Listeria, mice were infected i.p. either with 1 x
104 WT or 1 x 106
actA L. monocytogenes, i.e., the bacterial doses that
induced the maximal numbers of intracerebral
Listeria-specific T cells. In both groups of mice, systemic
listeriosis developed with detection of the respective strains of
L. monocytogenes in the spleen. Although a higher number of
actA L. monocytogenes was used for infection as compared
with the WT strain (1 x 106 bacteria vs
1 x 104 bacteria), the CFU of
actA
L. monocytogenes was lower in the spleen as compared with
infection with WT Listeria at day 5 p. i. (Fig. 2
A). In addition, the
actA mutant was completely eliminated from the spleen at
day 7 p.i., whereas clearance of WT L. monocytogenes
was delayed up to day 14 p.i. (Fig. 2
A). Both strains
of L. monocytogenes did not spread to the brain up to day
50 p.i. as evidenced by assessment of CFU. Moreover, the absence
of Listeria from the brain was confirmed by PCR (Fig. 2
B). In addition, L. monocytogenes was not
identified either in the brain parenchyma or in the ventricular system
of mice infected i.p. by immunohistochemistry (data not shown).
|
actA L.
monocytogenes did not result in invasion of the brain by the
pathogen, but, nevertheless, induced an intracerebral
Listeria-specific CD4 and CD8 T cell response. Because
infection with 1 x 106
actA L.
monocytogenes induced the strongest Listeria-specific
CD4 and CD8 T cell response in the brain; in addition, the
actA mutant was cleared from mice at the onset of
intracerebral Listeria-specific T cell responses (Figs. 1
actA mutant was
used for additional experiments. Kinetics of Ag-specific CD4 and CD8 T cells in the brain after primary and secondary infection
The kinetics of CD4 and CD8 T cell homing to the brain was
monitored after primary and secondary i.p. infection with
actA
L. monocytogenes. After primary infection, the frequencies of both
CD4 and CD8 T cells peaked at day 7 p.i. (Fig. 3
A). Thereafter, the frequency
of both T cell populations slowly declined, reaching baseline levels of
uninfected mice at day 50 p.i. Interestingly, the kinetics of the
individual Listeria-specific CD4 and CD8 T cell populations
appeared to be synchronized and paralleled the kinetics of CD4 and CD8
T cell frequency (Fig. 3
B). Like the kinetics of T cell
frequency, LLO9199 and
p60217225 CD8 T cells as well as
LLO190201-specific CD4 T cells peaked on day 7
of primary infection and decreased thereafter (Fig. 3
B). A
low number of Listeria-specific T cells, corresponding to
the epitopes LLO9199,
p60217225, LLO190201,
persisted intracerebrally until at least day 50 p.i. The magnitude
of Listeria-specific T cell responses to individual epitopes
showed a clear hierarchy. At day 7 p.i., the T cell response
against the dominant CD8 T cell epitope
LLO9199, was >2-fold increased as compared
with the subdominant CD8 T cell epitope
p60217225, and
3-fold higher than that of
the dominant CD4 T cell epitope LLO190201. A
p60367378-specific CD4 T cell response was not
detectable throughout primary infection (Fig. 3
B).
|
Homing of activated CD4 and CD8 T cells to specific compartments of the CNS after i.p. infection
To investigate whether these T cells were recruited to distinct
compartments of the brain on systemic Listeria infection,
immunohistochemical studies were conducted (Fig. 4
). On primary infection, both CD4 and
CD8 T cells homed to the leptomeninges and the choroid plexus but did
not cross the blood-brain barrier to enterthe brain parenchyma.
Secondary infection led to an increase in the number of both CD4 and
CD8 T cells predominantly in the leptomeninges (Fig. 4
, A
and B). Moreover, a few CD4 and CD8 T cells homed to the
choroid plexus (Fig. 4
, C and D) and were even
observed in the brain parenchyma (Fig. 4
, E and
F). In addition, some macrophages were detected.
|
after restimulation
with LLO190201 and
LLO9199, respectively, whereas intracerebral
CD4 and CD8 T cells of uninfected animals did not produce IFN-
after
peptide restimulation (Fig. 5
without peptide restimulation, although
restimulation with peptides further increased the IFN-
production.
In contrast, at day 28 p.i., restimulation with
Listeria-specific peptides was required to induce IFN-
production of CD4 and CD8 T cells. Both at days 7 and 28 p.i.,
intracerebral IFN-
-producing CD4 and CD8 T cells had an activated
CD44highCD62 ligand-
phenotype (data not shown). These findings indicate that i.p. infection
induced the recruitment of IFN-
-producing CD4 and CD8 T cells to the
brain, and that Listeria-specific T cells persisting in the
brain terminated their IFN-
production but were able to rapidly
restart production of this cytokine after stimulation with
Listeria-specific peptides. In contrast to T cells and
macrophages, intracerebral NK cells, dendritic cells, B cells, and
granulocytes were not detected by flow cytometry after primary and
secondary infection (data not shown).
|
Having established that activated Listeria-specific T
cells were recruited to and persisted in the brain, an adoptive
transfer experiment and a cytotoxic T cell assay were conducted to
further identify the functional role and activity of these
intracerebral T cells. At day 7 post-i.p. Listeria
infection, leukocytes were isolated from the brain and used for
adoptive transfer. Recipient mice were infected intracerebrally with
1 x 102
actA L.
monocytogenes, and immediately thereafter, recipient mice received
either 3 x 106 cerebral leukocytes
including CD4 and CD8 T cells, macrophages, and microglia (group 1),
cerebral leukocytes depleted of T cells (group 2), or PBS only (group
3) in the absence of cells. Three days p.i., significantly reduced
numbers of Listeria were recovered from the brains and
spleens of recipient mice having received the whole population of
cerebral leukocytes as compared with mice having received either T
cell-depleted cerebral leukocytes or PBS only (Fig. 6
).
|
|
Having established that protective Listeria-specific T
cells were recruited to the brain, factors that might regulate the size
of the intracerebral T cell pool were analyzed. To investigate whether
the induction and expansion of Listeria-specific CD4 and CD8
T cells in the spleen and their recruitment to the brain were dependent
on the period of bacterial presence in the host, mice were treated with
ampicillin from day 2 to 7 p.i. This regimen cleared
Listeria within 48 h from spleen and liver (data not
shown) but did not effect the frequency of Listeria-specific
CD8 T cells in the spleen and the brain (Fig. 8
A). However, ampicillin
treatment significantly reduced the frequency of
Listeria-specific CD4 T cells in spleen and brain (Fig. 8
A). These results suggest that the induction and expansion
of Listeria-specific CD8 T cells in the spleen as well as
their recruitment to the brain are programmed very early during
infection, whereas an optimal induction of Listeria-specific
CD4 T cells in the spleen requires a prolonged exposure to the
pathogen.
|
Cross-regulation of CD4 and CD8 T cells for the induction of Listeria-specific CD4 and CD8 T cells in the spleen and their recruitment to the brain
To evaluate the role of CD4 and CD8 T cells for the induction and
expansion of Listeria-specific CD4 and CD8 T cells in the
spleen and their recruitment to the brain, T cell depletion experiments
were performed. Depletion of peripheral CD8 T cells did not affect the
frequency of Listeria-specific CD4 T cells in the spleen,
but significantly reduced the frequency of these cells in the brain
(Fig. 9
A). The functional
importance of CD8 T cells for the recruitment of
LLO190201 CD4 T cells to the brain is
illustrated by the reduced brain-spleen ratio of specific CD4 T cells
in CD8-depleted mice as compared with control Ab-treated animals (Fig. 9
B). Depletion of peripheral CD4 T cells before the
infection reduced the frequency of Listeria-specific CD8 T
cells in both the spleen and the brain (Fig. 9
C). A
calculation of brain-spleen ratios revealed that CD4 depletion strongly
reduced the recruitment of LLO9199-specific CD8
T cells to the brain (Fig. 9
D). Thus, for
Listeria-specific CD8 T cells, both the induction in the
spleen and the recruitment to the brain were largely dependent on CD4 T
cells. In contrast, for Listeria-specific CD4 T cells only,
the recruitment to the brain, but not the induction in the spleen, was
dependent on CD8 T cells. These findings illustrate different
requirements for an optimal induction of Listeria-specific
CD4 and CD8 T cells in the spleen and their recruitment to the brain.
Additionally, there was clear evidence for a cross-regulation of CD4
and CD8 T cells in these processes.
|
| Discussion |
|---|
|
|
|---|
Infection i.p. with L. monocytogenes induced homing of
activated Listeria-specific CD4 and CD8 T cells to the
brain. The extent of invasion of Listeria-specific T cells
was correlated to the dose of infection, and a low number of as few as
100 WT or actA-deficient L. monocytogenes
injected i.p. were sufficient to induce homing of
Listeria-specific CD4 and CD8 T cells to the brain. Thus,
the induction of T cell surveillance of the brain requires only
exposure to a low dose of Listeria, and even small numbers
of highly attenuated L. monocytogenes, severely impaired in
their intracellular movement and their capacity to spread from cell to
cell, still induced this process. Nevertheless, the frequency of
intracerebral Listeria-specific CD4 and CD8 T cells was
lower in mice infected with identical numbers of
actA
than that of WT Listeria. Because bacteria were consistently
absent from the brain, it is unlikely that these T cells were primed
and expanded in the brain. In contrast, the infection of peripheral
lymphatic organs by L. monocytogenes and the presence of
Listeria-specific CD4 and CD8 T cells in the spleen suggest
that intracerebral Listeria-specific T cells are primed and
activated in peripheral lymphatic organs and are subsequently recruited
to the brain. The activated phenotype of intracerebral T cells was
illustrated by their spontaneous IFN-
production and their
CD44highCD62 ligand-
phenotype. This scenario is in agreement with studies from Hickey et
al. (14) demonstrating in adoptive T cell transfer
experiments that activated but not naive T cells home to the normal
brain. Recently, it has been shown that in TCR-transgenic mice naive T
cells, specific for a cerebral autoantigen, are recruited to the CNS
and are tolerized in the brain parenchyma (18). This
process may be of particular importance to prevent development of
cerebral autoimmune diseases, but in our infectious disease model
intracerebral Listeria-specific cells were not only
activated but also rapidly produced IFN-
on restimulation with
Listeria peptides and, more importantly, protected against
cerebral listeriosis. Thus, intracerebral Listeria-specific
T cells were functionally active and were not tolerized by the
microenvironment of the brain.
In the CNS, CD4 and CD8 T cells preferentially resided in the leptomeninges and, in lower numbers, in the choroid plexus. Interestingly, these anatomic regions correspond to the predilection and entry sites of L. monocytogenes in cerebral listeriosis (19, 20). Thus, intracerebral T cells were positioned optimally to prevent spread of Listeria to the brain and development of cerebral listeriosis. Only on secondary infection did a few CD4 and CD8 T cells cross the blood-brain barrier and move into the brain parenchyma. Previously, it has been shown that in the adoptive T cell transfer model the same anatomic structures were infiltrated by systemically applied activated T cells (14, 21), indicating that peripheral T cells preferentially home to these anatomic compartments of the normal CNS. In the adoptive transfer model, T cells residing in the brain parenchyma rapidly underwent apoptosis irrespective of their Ag specificity (22). This latter finding and the absence of a stimulus for leptomeningeal and choroid plexus T cells to cross the blood-brain barrier, i.e., Listeria infection of the brain parenchyma, may explain why only low numbers of CD4 and CD8 T cells resided in the brain parenchyma after systemic infection with L. monocytogenes.
The number of intracerebral Listeria-specific CD4 and CD8 T cells peaked at day 7 after primary and secondary infection, thereby corresponding to the kinetics of Listeria-specific CD4 and CD8 T cell responses in the spleen (23) (D. Schlüter, unpublished data). In addition, the hierarchy of LLO190201 and p60367378-specific CD4 T cells and LLO9199- and p60217225-specific CD8 T cells was conserved in the brain as compared with the spleen (10, 23), indicating that the microenvironment of the brain does not alter the hierarchy of T cell responses. Beyond day 7 of primary and secondary infection, the number of intracerebral Listeria-specific T cells declined; nevertheless, Listeria-specific T cells persisted for at least 50 days after primary and secondary infection in the brain. Such a long-lasting persistence of Listeria-specific T cells may be due to either a persistence of these cells in the brain or by their continuous recruitment to the brain. Because Listeria did not infect the brain in the course of infection, it is highly unlikely that intracerebral Listeria Ag was the driving factor maintaining Listeria-specific T cells in the brain. Whereas the preferential persistence of pathogen-specific CD8 T cells in nonlymphoid organs is well documented for extracerebral viral and bacterial peripheral infections including listeriosis (24, 25, 26), a few studies have shown that T cells are able to persist in the brain. On intracerebral infection with neurotropic influenza virus, virus-specific CD8 T cells persisted for at least 320 days after viral clearance from the brain (27). This latter experiment and our findings illustrate that under both experimental conditions, i.e., a systemic and extracerebrally confined bacterial infection and a viral CNS infection, pathogen-specific T cells are able to persist in the brain for an extended period of time in the absence of a pathogen. Such persistence of intracerebral T cells is in sharp contrast to autoimmune CNS disorders, during which autoreactive T cells are rapidly eliminated from the brain by apoptosis (22, 28).
Importantly, intracerebral Listeria-specific T cells were
functionally active and reduced bacterial load after cerebral infection
with L. monocytogenes. Thus, intracerebral
Listeria-specific T cells can be considered as one important
line of defense, which may protect the host together with systemic
Listeria-specific T cells and other cell populations
including macrophages, granulocytes, and NK cells against cerebral
listeriosis. Because both intracerebral CD4 and CD8 T cells produced
IFN-
, a cytokine of key importance in listeriosis (29),
but intracerebral CD8 T cells did not exhibit cytotoxic activity,
protection is most probably conferred by production of protective
cytokines. This assumption is in agreement with the observation that
CD8 T cells from perforin-deficient mice are able to confer protection
against Listeria (6). The finding that
cytotoxicity was confined to splenic
LLO9199-specific CD8 T cells indicates an
organ-specific regulation of the phenotype and function of
Listeria-specific CD8 T cells and may be protective to the
highly vulnerable brain. Remarkably, the missing cytotoxic activity of
intracerebral CD8 T cells is distinct from the preferential
localization of Listeria-specific cytotoxic effector memory
cells in extracerebral nonlymphoid tissues (24) and
further illustrates a CNS-specific regulation of the intracerebral T
cell response. An organ-specific regulation of CD8 T cells in
peripheral lymph node, liver, spleen, and intestinal lamina propria has
also been observed in oral infection with Listeria
(17, 30).
Recently, it has been shown that the magnitude and kinetics of Listeria-specific CD8 T cell responses in the spleen are determined as early as within the first 24 h of bacterial infection (31). The present study confirms and extends these findings by the observation that after CD8 T cell induction in the spleen, subsequent recruitment of the cells to the brain was also determined within the first 48 h of infection. In contrast, ampicillin treatment caused a decrease of the frequency of Listeria-specific CD4 T cells in the spleen, indicating that an optimal induction of Ag-specific CD4 T cells required a prolonged exposure to Listeria. The frequency of both intracerebral Listeria-specific CD4 and CD8 T cells was largely dependent on the magnitude of the splenic T cell responses and the brain-spleen ratios of Listeria-specific CD4 and CD8 T cells were not influenced by antibiotic abridgement of Ag exposure.
In addition to the magnitude of the peripheral T cell response, the
frequency of intracerebral Listeria-specific T cells was
regulated by a CD4 and CD8 T cell-dependent recruitment of T cells to
the brain: depletion of CD4 T cells reduced the recruitment of
Listeria-specific CD8 T cells; and vice versa depletion of
CD8 T cells reduced the recruitment of Listeria-specific CD4
T cells to the brain. How CD4 and CD8 T cells regulate the recruitment
of Listeria-specific T cells to the brain is unknown but may
include the induction of cell adhesion molecules on brain endothelial
cells by cytokines. In the normal brain, only low levels of cell
adhesion molecules are expressed; however, in infectious and autoimmune
diseases they are rapidly up-regulated by cytokines including IFN-
and critically regulate the recruitment of T cells to the brain
(21, 32, 33, 34, 35, 36, 37). Thus, a depletion of cytokine-producing T
cells may result in an impaired recruitment of T cells to the brain via
the reduced expression of cell adhesion molecules on brain vessel
endothelial cells. The assumption that IFN-
paves the way for
Listeria-specific T cells to the brain is further supported
by the observation that intracerebral CD4 and CD8 T cells spontaneously
produced IFN-
at day 7 p.i.
In conclusion, the present study identifies a novel pathway how the brain is surveilled and protected from pathogens during a systemic infection, which is strictly confined to peripheral organs. The active, Ag-specific T cell-mediated immunosurveillance of the brain illustrates that the brain is well integrated into immunological circuits intended to protect the host from life-threatening cerebral infections.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Dirk Schlüter, Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany. E-mail address: dirk.schlueter{at}imh.ma.uni-heidelberg.de ![]()
3 Abbreviations used in this paper: WT, wild type; LLO, listeriolysin; p.i., postinfection; LCA, leukocyte common Ag. ![]()
Received for publication March 12, 2002. Accepted for publication June 12, 2002.
| References |
|---|
|
|
|---|
. J. Immunol. 164:6444.
B (RelA/p50) activation induced by lipoteichoic acid and bacterial phospholipases and mediated by I
B
and I
B
degradation. Proc. Natl. Acad. Sci. USA 94:9394.
receptor. Science 259:1742.
receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. Am. J. Pathol. 154:1549.
4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57.This article has been cited by other articles:
![]() |
D. A. Drevets, J. E. Schawang, M. J. Dillon, M. R. Lerner, M. S. Bronze, and D. J. Brackett Innate Responses to Systemic Infection by Intracellular Bacteria Trigger Recruitment of Ly-6Chigh Monocytes to the Brain J. Immunol., July 1, 2008; 181(1): 529 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Ruiz, L. Wilden, W. Muller, W. Stenzel, A. Brunn, H. Miletic, D. Schluter, and M. Deckert Molecular Mimicry between Neurons and an Intracerebral Pathogen Induces a CD8 T Cell-Mediated Autoimmune Disease J. Immunol., June 15, 2008; 180(12): 8421 - 8433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deckert, S. Virna, M. Sakowicz-Burkiewicz, S. Lutjen, S. Soltek, H. Bluethmann, and D. Schluter Interleukin-1 Receptor Type 1 Is Essential for Control of Cerebral but Not Systemic Listeriosis Am. J. Pathol., March 1, 2007; 170(3): 990 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
|